Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
Ilaria VicentinCristina MosconiEnrico GaranziniCarlo SpositoMatteo SerenariVincenzo BuscemiMartina VernaCarlo SpreaficoRita GolfieriVincenzo MazzaferroLuciano De CarlisMatteo CesconGiorgio ErcolaniAngelo VanzulliAlessandro CucchettiPublished in: European radiology (2021)
• The review of 180 radiological exams of patients with hepatocellular carcinoma before and after neo-adjuvant therapies showed that the concordance among three different raters on mRECIST diagnosis was substantial. • The inter-observer reliability on fulfilment of transplant criteria slightly decreased when evaluated through CT and after loco-regional therapies. • The radiological diagnosis of complete response after neo-adjuvant therapies was predictive of complete pathological response in only 51.6% of cases.